Timothy H. Wilson

Effect of Dutasteride on the Risk of Prostate Cancer

Gerald L. Andriole, David G. Bostwick, Otis W. Brawley et al. · New England Journal of Medicine · 2010 · 1.1K citations · Full text

Medicine, Pharmacology, Urology +12

Marked Suppression of Dihydrotestosterone in Men with Benign Prostatic Hyperplasia by Dutasteride, a Dual 5α-Reductase Inhibitor

Richard V. Clark, David Hermann, Glenn R. Cunningham et al. · The Journal of Clinical Endocrinology & Metabolism · 2004 · 460 citations

Life Sciences, Pharmacology, Pharmacotherapy +15

The importance of dual 5α-reductase inhibition in the treatment of male pattern hair loss: Results of a randomized placebo-controlled study of dutasteride versus finasteride

Elise A. Olsen, Maria Hordinsky, David Whiting et al. · Journal of the American Academy of Dermatology · 2006 · 294 citations

Life Sciences, Biochemistry, Pharmacotherapy +15

Comparison of dutasteride and finasteride for treating benign prostatic hyperplasia: the Enlarged Prostate International Comparator Study (EPICS)

J. Curtis Nickel, Peter Gilling, Teuvo L.J. Tammela et al. · British Journal of Urology · 2011 · 218 citations

Medicine, Pharmacology, Urology +13

Clinical outcomes after combined therapy with dutasteride plus tamsulosin or either monotherapy in men with benign prostatic hyperplasia (BPH) by baseline characteristics: 4‐year results from the randomized, double‐blind Combination of Avodart and Tamsulosin (CombAT) trial

Claus G. Roehrborn, Jack Barkin, Paul Siami et al. · British Journal of Urology · 2011 · 116 citations

Medicine, Pharmacology, Pharmacotherapy +15